Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana.
Jane Metrik, Damaris J Rohsenow, Peter M. Monti, John E McGeary, Travis A R Cook, Harriet de Wit, Margaret Haney, Christopher W Kahler
Experimental and Clinical Psychopharmacology August 1, 2009 DOI: 10.1037/a0016502 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Pilot study using a 2 x 2 balanced-placebo design Peer reviewed |
|---|---|
| Sample size | 20 |
| Population | Marijuana smokers (mean age = 20 years; 25% female) |
| Dose | 2.8% THC |
| Topics | Cannabis |
| Keywords | Humans Placebos Pilot projects Attitude Marijuana smoking Affect Adolescent Adult Female Dronabinol |
| Key points | Expectancy manipulation produced large main effects on ratings of cigarette potency, strength, taste, smell, and satisfaction, and on observed smoking behavior. Pharmacologic effects were particularly evident for self-reported physical reactions to marijuana and for cigarette potency and satisfaction ratings. The authors report that the balanced-placebo design is feasible for marijuana research and that the results are promising for future studies of pharmacology and expectancy. |
Abstract
Although alcohol and nicotine administration studies have demonstrated that manipulating subjects' expectancies regarding drug content affects drug response, research with marijuana has not adequately studied drug expectancy effects. The present pilot study was the first to evaluate the credibility and effect of expectancy manipulation on subjective measures and smoking patterns using a marijuana administration balanced-placebo design (BPD). In a 2 x 2 instructional set (told delta-9-tetrahydrocannabinol [THC] vs. told no THC) by drug (smoked marijuana with 2.8% THC vs. placebo) between-subjects design, the authors examined the effect of marijuana expectancy manipulation and the pharmacologic effect on affective and physiologic measures, cigarette ratings, and smoking behavior with 20 marijuana smokers (mean age = 20 years; 25% female). Large main effects of expectancy were found on ratings of cigarette potency, strength, taste, smell, and satisfaction, and observed smoking behavior. Pharmacologic effects were particularly evident for self-reported physical reactions to marijuana and cigarette potency and satisfaction ratings. This study demonstrated the feasibility of the BPD research with marijuana and yielded promising results for future studies examining the independent and combined effects of marijuana pharmacology and expectancies.
Comparable studies
Other randomized controlled trials on cannabis, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment Healthy participants | 2012 | Randomized controlled trial | n = 48 |
| Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing Healthy, English-native, right-handed men who had used cannabis 15 times or less in... | 2009 | Double-blind, randomized, placebo-controlled crossover trial | n = 15 |
| Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers Healthy male subjects | 2012 | Randomized controlled trial | n = 16 |
| Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol Healthy, native English-speaking, right-handed men of white race/ethnicity who had used... | 2009 | Randomized controlled trial | n = 15 |
| Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition Healthy volunteers with a history of light cannabis use | 2019 | Randomized, double-blind, within-subjects crossover | n = 14 |
Citations in the library
Cited by 12
- Prediction of Psilocybin Response in Healthy Volunteers PLoS One February 17, 2012
- Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images Journal of Psychopharmacology May 13, 2012
- Human behavioral pharmacology of psychedelics. Advances in pharmacology (San Diego, Calif.) 2022
- Tolerability, assessment, and prediction of psilocybin-induced altered states of consciousness Zurich Open Repository and Archive (University of Zurich) 2012
- The Novelty of Ayahuasca Scale and the prediction of intentions to use Journal of Psychedelic Studies March 12, 2020
and 7 more in the library
Cites 4
- Acute marijuana effects on human risk taking. Neuropsychopharmacology April 2005
- Adverse effects of cannabis on health: an update of the literature since 1996. Progress in neuro-psychopharmacology & biological psychiatry August 2004
- Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology July 2003
- Increased susceptibility to memory intrusions and the Stroop interference effect during acute marijuana intoxication. Psychopharmacology 1987